menu
    • menu

    Company profile for Apogee Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Apogee Therapeutics is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and other inflammatory and immune (I&I) diseases with high unmet needs. Its pipeline of differentiated antibody therapeutics targets well-established biological drivers and development pathways, with an initial focus on making impactful advancement...
    Apogee Therapeutics is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and other inflammatory and immune (I&I) diseases with high unmet needs. Its pipeline of differentiated antibody therapeutics targets well-established biological drivers and development pathways, with an initial focus on making impactful advancements in the treatment of atopic dermatitis and chronic obstructive pulmonary disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Apogee TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    221 Crescent St Waltham, MA 02453
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://apogeetherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/apogee-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Apogee Therapeutics Updates Pipeline Progress & Q3 2025 Updates
    Apogee Therapeutics Updates Pipeline Progress & Q3 2025 Updates

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184408/0/en/Apogee-Therapeutics-Provides-Pipeline-Progress-and-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Apogee Therapeutics Reports Positive Phase 1 Interim Results
    Apogee Therapeutics Reports Positive Phase 1 Interim Results

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184340/0/en/Apogee-Therapeutics-Announces-Positive-Interim-Phase-1-Results-from-Healthy-Volunteer-Trial-of-APG333-its-Novel-Half-Life-Extended-TSLP-Antibody.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Apogee Therapeutics Closes Public Offering, Raises $345M
    Apogee Therapeutics Closes Public Offering, Raises $345M

    10 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/10/3165093/0/en/Apogee-Therapeutics-Inc-Announces-Closing-of-Public-Offering-and-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Shares-for-Gross-Proceeds-of-345-Million.html

    GLOBENEWSWIRE
    10 Oct 2025
    Share Share
    Apogee Therapeutics Prices $300M Public Offering
    Apogee Therapeutics Prices $300M Public Offering

    08 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/09/3163822/0/en/Apogee-Therapeutics-Inc-Announces-Pricing-of-300-Million-Underwritten-Public-Offering.html

    GLOBENEWSWIRE
    08 Oct 2025
    Share Share
    Apogee Therapeutics Plans Underwritten Public Offering
    Apogee Therapeutics Plans Underwritten Public Offering

    08 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/08/3163716/0/en/Apogee-Therapeutics-Inc-Announces-Proposed-Underwritten-Public-Offering.html

    GLOBENEWSWIRE
    08 Oct 2025
    Share Share
    Apogee Ph 2 APEX Trial Data of APG777 Revealed at EADV Congress
    Apogee Ph 2 APEX Trial Data of APG777 Revealed at EADV Congress

    11 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/11/3148456/0/en/Apogee-Therapeutics-Announces-Late-Breaker-Presentation-of-16-Week-Data-from-Phase-2-APEX-Trial-of-APG777-for-Moderate-to-Severe-Atopic-Dermatitis-at-the-Upcoming-European-Academy-.html

    GLOBENEWSWIRE
    11 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search